• Home
  • Mutual Funds
  • ITI Pharma and Healthcare Fund Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

₹211 Cr

Lock In Period

N/A

Expense Ratio

2.35

Benchmark

NIFTY Healthcare Total Return Index

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.

Summary

Latest details for ITI Pharma and Healthcare Fund Growth include a ₹15.9207 NAV as of Apr 30,2026 and returns since inception of 70.87%. Minimum investments start at SIP ₹500. The ITI Pharma and Healthcare Fund Growth AUM is ₹211 Cr, with a lock-in of N/A years, expense ratio of 2.35%, and benchmark NIFTY Healthcare Total Return Index. Exit load is - If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.. In the growth review for 1M Month/Year, the fund recorded 6.47% returns, against a category average of -0.53% and a category best of 25.38%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M6.47-0.5325.38
6M-3.140.5692.10
1Y0.383.33242.40
3Y19.558.62352.36

Portfolio Analysis

  • Equity: 99.18%
  • Debt: 0.82%
  • Others
As on: 2026-03-31
View allocation % by

1. Sun Pharmaceutical Industries Limited11.80%
2. Divi's Laboratories Limited8.77%
3. Torrent Pharmaceuticals Limited5.28%
4. Aurobindo Pharma Limited4.99%
5. Lupin Limited4.20%
6. Laurus Labs Limited3.65%
7. Alkem Laboratories Limited3.12%
8. Neuland Laboratories Limited2.66%
9. Abbott India Limited2.32%
10. Glenmark Pharmaceuticals Limited2.15%
11. Cohance Lifesciences Limited2.09%
12. Dr. Reddy's Laboratories Limited1.87%
13. Mankind Pharma Limited1.85%
14. Sai Life Sciences Limited1.82%
15. IPCA Laboratories Limited1.70%
16. Cipla Limited1.67%
17. Biocon Limited1.29%
18. FDC Limited1.16%
19. Onesource Specialty Pharma Limited1.15%
20. Piramal Pharma Limited1.10%
21. GlaxoSmithKline Pharmaceuticals Limited1.00%
22. Orchid Pharma Limited0.83%
23. Shilpa Medicare Limited0.82%
24. Caplin Point Laboratories Limited0.74%
25. Zydus Lifesciences Limited0.69%
26. AstraZeneca Pharma India Limited0.69%
27. Supriya Lifescience Limited0.67%
28. Syngene International Limited0.41%

1. Apollo Hospitals Enterprise Limited6.60%
2. Max Healthcare Institute Limited5.50%
3. Fortis Healthcare Limited2.91%
4. Aster DM Healthcare Limited2.32%
5. Park Medi World Limited1.49%
6. Healthcare Global Enterprises Limited1.24%
7. Rainbow Childrens Medicare Limited1.11%

1. Linde India Limited1.39%

1. SBI Life Insurance Company Limited1.25%

1. Sumitomo Chemical India Limited1.21%

1. Shaily Engineering Plastics Limited1.11%

1. Jubilant Ingrevia Limited1.06%

About Fund

ITI Pharma and Healthcare Fund Growth managed by ITI Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹211 Crore. The fund benchmarks its performance against the NIFTY Healthcare Total Return Index while maintaining an expense ratio of 2.35. Under the expert guidance of Dhimant Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhimant Shah

Mr. Dhimant is a Commerce Graduate and holds a CA Degree. He has over 16 years of experience in stock markets. Previously, he has also worked with Reliance Asset Management Co. Pvt. Ltd (PMS), ASK Raymond James (PMS) as a Portfolio Manage, IL&FS Asset Management Co. Pvt. Ltd as Senior Research Analyst and HSBC Asset Management Co. Pvt. Ltd. as a Fund Manager.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundQuant ESG Integration Strategy Fund Growth0225.6 CR2.44
This FundAxis Innovation Fund Growth01039.28 CR2.28
This FundITI Pharma and Healthcare Fund Growth0211.3 CR2.35
This FundICICI Prudential PSU Equity Fund Growth01798.21 CR2.1
This FundNippon India Taiwan Equity Fund Growth3599.16 CR2.36
Fund Name1Y3Y
This FundQuant ESG Integration Strategy Fund Growth6.486357.6897
This FundAxis Innovation Fund Growth10.214759.4458
This FundITI Pharma and Healthcare Fund Growth0.383970.8672
This FundICICI Prudential PSU Equity Fund Growth12.5372107.208
This FundNippon India Taiwan Equity Fund Growth237.6946333.918

FAQs

ITI Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.35. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ITI Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 6.47%
  • 6 Months : -3.14%
  • 1 Year : 0.38%
  • 3 Years : 19.55%
Returns of ITI Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 15.9207 as on Apr 30,2026. Since inception, the return has been 70.87%.

You can invest in ITI Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ITI Pharma and Healthcare Fund Growth is ₹211 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ITI Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500